Gold

AMOMED Pharma

AMOMED Pharma

AMOMED Pharma GmbH is an international company based in Vienna, Austria. Since our establishment in 2006, we have grown into a renowned specialist for intensive care and emergency medicine, focusing on anesthesia, cardiology, endocrinology, neurology and psychiatry products. We are both an expert distribution partner for hospitals and a valuable partner for medical specialists, dedicated to providing the solutions they need.
Our products comprise the medication needed to relieve symptoms and significantly improve the quality of life, as well as medication that is primarily used in critical, life-threatening situations. That is why we maintain constant communication with medical specialists and focus on the real needs in medical practice to develop products in line with actual clinical requirements.
Highest quality standards, delivery reliability and a strong drive to excel as a team are fundamentally important to us. We act swiftly and flexibly to find the right solutions – in close consultation with medical specialists and for the benefit of patients. We share the responsibility for the smooth functioning of medical measures at the decisive moment. Whether owner or team members - at AMOMED Pharma, we are fully aware of the importance of our actions and are deeply committed to the far-reaching aspect of our work.
Baxter

Baxter

Baxter develops, manufactures and markets products and therapies that save and sustain the lives of people with hemophilia, immune disorders, cancers, kidney disease, malnutrition and other acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in pharmaceuticals, biotechnology and medical devices to create products that advance patient care worldwide.

Cytosorbents

Cytosorbents

CytoSorbents is a critical care immunotherapy company commercializing its CE approved CytoSorb, a safe and effective cytokine adsorber. CytoSorb is designed to attenuate the dysregulated, hyperinflammatory response („cytokine storm“) present in septic shock and other, non-infectious systemic hyperinflammatory states by reducing elevated levels of cytokines and other inflammatory mediators. This modulation of the immune response can lead to an improvement of hemodynamics, a reduction in the need for vasopressors and overall to an increased chance for recovery of organ functions and improved patient outcomes. CytoSorb is indicated in various hyperinflammatory states of infectious and non-infectious origin, e.g. after cardiac surgery, in cardiogenic shock, trauma, burns, pancreatitis and infection. So far it has been used safely and well tolerated in more than 27,000 single treatments worldwide. CytoSorb Therapy – REGAIN CONTROL!

Gambro

Gambro

The critical condition of the ICU patient requires sage, efficient and flexible therapeutic options. Gambro has used its know how in blood purification to develop innovative concepts to offer treatments for renal and liver failure.

Getinge

Getinge

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers equipment for surgical disciplines, cardiology and intensive care; the Extended Care business area offers products and services geared toward the hospital and elderly care markets, including solutions for preventing the risk of pressure ulcers and deep vein thrombosis, and the Infection Control business area features systems for preventing the occurrence and spread of infection. Its products comprise disinfectors, sterilizers, including low temperature sterilization solutions, information technology (IT) solutions, as well as advice, training and technical support. The Company's products are sold under the Getinge, Lancer, ArjoHuntleigh and MAQUET brands.

Our Diamond Partners

Become a partner too!

Social Media

  like us on Facebook

  follow us on Twitter

  join Discussion group

  join us on Linkedin

  newsletter sign up

  post on the blog